Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The <i>EXPeRT</i> Recommendations

Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low-grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease stages with low survival rates. This paper presents consensus recommendations on the diagnosis and treatment of pediatric patients with primary lung carcinomas and BC, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) in collaboration with the European Reference Network for Pediatric Oncology (ERN PaedCan).

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2026-03-15
DOI
https://doi.org/10.1002/1545-5017.70190
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

Yves Réguerre, A Agaimy, Ducou le Pointe H, Rainer Claus et al.
Pediatric Blood & Cancer
Neuroendocrine Tumor Research Advances
article

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

Yves Réguerre, A Agaimy, Ducou le Pointe H, Rainer Claus, Ewa Bień, Małgorzata Krawczyk, Michael Abele, S. Irtan, C. Daniel, D. Orbach, Calogero Virgone, Tal Ben‐Ami, Ines B. Brecht, Gianni Bisogno, Dominik T. Schneider, Andrea Ferrari, Constantin Lapa, Ricardo Lopez‐Almaraz, Michaela Kuhlen, Maja Mazic Cesen
article en

Abstract

Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low-grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease stages with low survival rates. This paper presents consensus recommendations on the diagnosis and treatment of pediatric patients with primary lung carcinomas and BC, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) in collaboration with the European Reference Network for Pediatric Oncology (ERN PaedCan).

Pediatric Blood & Cancer
University of Padua (IT), Technische Hochschule Augsburg (DE), University of Augsburg (DE), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), University of Milan (IT), Université Paris Sciences et Lettres (FR), Kaplan Medical Center (IL), Ljubljana University Medical Centre (SI), Sorbonne Université (FR), Hôpital Armand-Trousseau (FR), Centre Hospitalier Universitaire de La Réunion (RE), Universitätsklinikum Erlangen (DE), BioCruces Health research Institute (ES), Assistance Publique – Hôpitaux de Paris (FR), University Children's Hospital Tübingen (DE), Klinikum Dortmund (DE), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Gdańsk Medical University (PL), Institut Curie (FR)
Openalex Percentile: Top 22%
Neuroendocrine Tumor Research Advances
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.